1. A pomegranate peel extract as inhibitor of SARS-CoV-2 Spike binding to human ACE2 (in vitro): a promising source of novel antiviral drugs
- Author
-
Annalisa Tito, Fabio Apone, Ivan Conte, Luciano Pirone, Antonio Colantuono, Giuliana Giamundo, Emilia Pedone, Daniela Intartaglia, and Paola Vitaglione
- Subjects
chemistry.chemical_classification ,Protease ,medicine.medical_treatment ,Biology ,Pharmacology ,In vitro ,Virus ,Enzyme ,chemistry ,Polyphenol ,Viral entry ,In vivo ,medicine ,Glycoprotein - Abstract
Plant extracts are rich in bioactive compounds, such as polyphenols, sesquiterpenes and triterpenes, with potential antiviral activities. As the dramatic outbreak of the pandemic COVID-19, caused by the SARS-CoV-2 virus, thousands of scientists are working tirelessly trying to understand the biology of this new virus and the disease pathophysiology, with the main goal to discover effective preventive treatments and therapeutic agents. Plant-derived secondary metabolites may play key roles in preventing and counteracting the rapid spread of SARS-CoV-2 infections by inhibiting the activity of several viral proteins, in particular those involved in the virus entry into the host cells and its replication. In this study, by using different in vitro approaches, we uncovered the role of a pomegranate peel extract in attenuating the interaction between the SARS-CoV-2 Spike glycoprotein and the human Angiotensin-Converting Enzyme 2 (ACE2) receptor, and in inhibiting the activity of the virus 3CL protease. Although further studies will be determinant to assess the efficacy of this extract in vivo, our results open up new promising opportunities to employ natural extracts for the development of effective and innovative therapies in the fight against SARS-CoV-2.
- Published
- 2020